|
Similar Survival with Two Ovarian Cancer Strategies (CME/CE, with audio)
(MedPage Today) -- Patients with bulky, advanced ovarian cancer survived just as long whether treated with neoadjuvant chemotherapy and surgery or with primary surgery followed by adjuvant chemotherapy, investigators in a multinational trial reported.
Preventive Surgery Works for BRCA Mutation Carriers (CME/CE, with video)
(MedPage Today) -- Prophylactic surgery can reduce the high risk of breast and ovarian cancer among BRCA mutation carriers and can actually improve survival, researchers affirmed.
Risky Births Fare Better at Quality Centers (CME/CE)
(MedPage Today) -- Very low birth weight and very premature births that occur in less-specialized centers are more likely to result in death for the infant, according to a review of several studies.
Birth Late or Early Ups Chance of CP (CME/CE)
(MedPage Today) -- Infants delivered either early or late are at increased risk of cerebral palsy, a large Norwegian population-based study found.
Anti-HER2 Drug Fails to Win FDA Fast Track
WASHINGTON (MedPage Today) -- The Food and Drug Administration turned down a request for accelerated approval of Roche-Genentech's trastuzumab-DM1 for treatment of HER2-positive breast cancer.
Breast-Feeding Keeps Diabetes at Bay (CME/CE)
(MedPage Today) -- Women who don't breast-feed their babies are at an increased risk for type 2 diabetes, researchers found.
BPA Affects Hormones in Men (CME/CE)
(MedPage Today) -- Increased exposure to a chemical common to food and drink packaging predicted higher testosterone levels in men, suggesting the chemical bisphenol A (BPA) effects endocrine changes in men, data from a cohort study showed.
Forceps Delivery Linked to Later Pelvic Organ Prolapse (CME/CE)
(MedPage Today) -- The use of forceps during delivery is associated with muscle damage that can lead to later pelvic organ prolapse, Australian researchers found.
|
